MeSH Review:
Hip Dysplasia, Canine
- Fourteen week clinical evaluation of an oral antioxidant as a treatment for osteoarthritis secondary to canine hip dysplasia. Impellizeri, J.A., Lau, R.E., Azzara, F.A. The Veterinary quarterly. (1998)
- Inflammation-responsive transcription factors SAF-1 and c-Jun/c-Fos promote canine MMP-1 gene expression. Ray, A., Shakya, A., Ray, B.K. Biochim. Biophys. Acta (2005)
- Canine hip dysplasia. 2: Control and treatment. Quinlan, T.J. New Zealand veterinary journal. (1975)